In daily medical practice, clinicians often make minor adjustments to a patient’s treatment plan, such as changing medications, updating dosages, or modifying administration methods. Most of the time, these changes improve symptoms and enhance quality of life. But sometimes, a routine adjustment can reveal something completely unexpected.
See more
Supplements for sensitive skin
Patient support
Teeth whitening kits
This was the case of a 55-year-old woman with chronic obstructive pulmonary disease (COPD). For years, her condition remained stable with her medications. Then, after switching to a new inhaler, she developed a rare and painful skin condition known as Sweet’s syndrome , a reaction so unusual that it may represent the first documented case related to inhaled therapy.
This story highlights why both patients and healthcare providers should remain alert to even subtle changes in the body, especially after medication adjustments.
The patient’s journey: from stability to sudden symptoms
The patient’s medical history included hypertension and long-term treatment for COPD. Her treatment plan included enalapril for blood pressure control and a formoterol inhaler for her respiratory condition. For years, her progress had been relatively good.
See more
Symptom monitoring
Inhalers for COPD
Clinical research
er lung function began to decline, her pulmonologist decided to adjust her regimen and prescribed a new combination inhaler containing indacaterol and glycopyrronium. This was a standard, evidence-based decision intended to improve her breathing and slow the progression of the disease.
However, just 48 hours after starting to use the new inhaler, the patient developed alarming symptoms:
Bright red, painful spots on the face and neck.
A mild fever
Without new cosmetics, changes in diet, or infections.
Recent sun exposure, but with adequate protection.
His sudden skin reaction and fever prompted an urgent referral to a dermatologist.
The diagnostic process: Discovering the sweet tooth syndrome
One of the biggest challenges in dermatology is distinguishing between conditions that appear similar. Rashes, plaques, and erythematous lesions can arise from dozens of causes, ranging from mild allergies to severe autoimmune disorders.
The initial working diagnoses included:
Contact dermatitis
Lupus erythematosus
Hives
Further investigation revealed the real culprit:
Blood tests ruled out common infections and autoimmune markers.
The new inhaler was immediately discontinued.
A skin biopsy was performed and pathology confirmed Sweet’s syndrome .
Treatment with oral corticosteroids was initiated, which resulted in a
See more
Medical literature and bibliography
Health problems
Medical services and facilities
A dramatic improvement in two days. The plaques disappeared, the fever subsided, and the pain decreased rapidly. What exactly is candy syndrome?
Acute febrile neutrophilic dermatosis shown by a medical animation image
Sweet’s syndrome, or acute febrile neutrophilic dermatosis , is a rare immune-mediated skin condition, first described in 1964 by Dr. Robert Sweet. It is characterized by:
Sudden, painful red or purple plaques or papules
The injuries were concentrated on the face, neck, torso, and hands.
It is accompanied by fever, fatigue, and joint pain.
Elevated white blood cell count, especially neutrophils
Known triggers
See more
Medical services and facilities
Medical literature and bibliography
Health problems
The exact cause is not fully understood, but it appears to be related to immune system dysregulation. Triggers include:
Infections (respiratory or gastrointestinal)
Hematological cancers, such as acute myeloid leukemia
Autoimmune or inflammatory diseases
Medications (antibiotics, antiepileptics, G-CSF, some vaccines)
Treatment usually involves systemic corticosteroids, which typically provide rapid relief.
Why this case stands out
What is atopic dermatitis? Causes and treatment? – Dermalogica Vietnam
The most surprising aspect of this case is that Sweet’s syndrome was triggered by an inhaled COPD medication . Until now, no case in the medical literature had linked the condition to inhaled therapies.
See more
Health problems
Medical services and facilities
Medical literature and bibliography
Clinical significance
Expanding the known triggers : Previously, Sweet’s syndrome was primarily associated with oral or injectable drugs. This case demonstrates that even inhaled medications can trigger rare immune responses.
Diagnostic challenges : Due to its rarity, the condition can easily be mistaken for more common skin rashes. Early biopsy is essential.
Role of primary care : General practitioners are often the first to detect unusual reactions. Prompt recognition and referral are vital. Lessons for physicians
1,349 stock images of foot eczema - Free and royalty-free stock images from Dreamstime
This case offers several important reminders for healthcare providers:
Stay alert after medication changes : even commonly used medications can trigger rare immune reactions.
Consider Sweet’s syndrome in cases of sudden, painful skin rashes with fever.
Use a broad differential diagnosis : carefully exclude lupus, dermatitis, and drug eruptions.
Act quickly with corticosteroids : they remain the most effective treatment.
Reporting rare cases : documentation expands medical knowledge and helps future doctors.
Patient’s perspective: Experiencing a rare reaction
Atopic dermatitis (eczema): causes, symptoms, treatments and medications
For the patient, what began as a standard inhaler change quickly turned into a distressing experience. The painful facial lesions overwhelmed him both physically and emotionally, affecting his self-confidence and social interactions.
Her rapid recovery with corticosteroids was reassuring, but the experience highlighted the anxiety patients face when dealing with rare and little-known diseases. For those with chronic conditions like COPD, trust in their treatment is paramount, making open communication with healthcare professionals especially important.
The broader implications
Atopic dermatitis (eczema): causes, symptoms, treatments and medications
For the patient, what began as a standard inhaler change quickly turned into a distressing experience. The painful facial lesions overwhelmed him both physically and emotionally, affecting his self-confidence and social interactions.
Her rapid recovery with corticosteroids was reassuring, but the experience highlighted the anxiety patients face when dealing with rare and little-known diseases. For those with chronic conditions like COPD, trust in their treatment is crucial, making open communication with healthcare professionals especially important.
0 Comment:
Enregistrer un commentaire